Aprepitant (patient information)

Aprepitant (patient information)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Aprepitant (patient information) is an antiemetic, neurokinin-1 receptor antagonist that is FDA approved for the prophylaxis of in combination with other antiemetic agents for the:

• acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin
• of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC)

Also, indicated for the prevention of postoperative nausea and vomiting (PONV). Common adverse reactions include alopecia, anorexia, asthenia/fatigue, constipation, diarrhea, headache, hiccups, nausea, hypotension, pruritus, pyrexia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)

Capsules of EMEND (aprepitant) are given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonist. The recommended dose of EMEND is 125 mg orally 1 hour prior to chemotherapy treatment (Day 1) and 80 mg orally once daily in the morning on Days 2 and 3.

• EMEND may be taken with or without food.
• EMEND (fosaprepitant dimeglumine) for Injection (115 mg) is a prodrug of aprepitant and may be substituted for oral EMEND (125 mg), 30 minutes prior to chemotherapy, on Day 1 only of the CINV regimen as an intravenous infusion administered over 15 minutes.

In clinical studies with EMEND, the following regimen was used for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:

In a clinical study with EMEND, the following regimen was used for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:

Prevention of Postoperative Nausea and Vomiting (PONV)

The recommended oral dosage of EMEND is 40 mg within 3 hours prior to induction of anesthesia. EMEND may be taken with or without food.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aprepitant (patient information) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aprepitant (patient information) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Aprepitant (patient information) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aprepitant (patient information) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aprepitant (patient information) in pediatric patients.

Contraindications

EMEND is contraindicated in patients who are hypersensitive to any component of the product.

EMEND is a dose-dependent inhibitor of cytochrome P450 isoenzyme 3A4 (CYP3A4). EMEND should not be used concurrently with pimozide, terfenadine, astemizole, or cisapride. Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of these drugs, potentially causing serious or life-threatening reactions.

Warnings

There is limited information regarding Aprepitant (patient information) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Aprepitant (patient information) Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Aprepitant (patient information) Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Aprepitant (patient information) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Aprepitant (patient information) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aprepitant (patient information) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Aprepitant (patient information) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Aprepitant (patient information) in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Aprepitant (patient information) in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Aprepitant (patient information) in geriatric settings.

Gender

There is no FDA guidance on the use of Aprepitant (patient information) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Aprepitant (patient information) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Aprepitant (patient information) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Aprepitant (patient information) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Aprepitant (patient information) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Aprepitant (patient information) in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Aprepitant (patient information) Administration in the drug label.

Monitoring

There is limited information regarding Aprepitant (patient information) Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Aprepitant (patient information) and IV administrations.

Overdosage

There is limited information regarding Aprepitant (patient information) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Aprepitant (patient information) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Aprepitant (patient information) Mechanism of Action in the drug label.

Structure

There is limited information regarding Aprepitant (patient information) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Aprepitant (patient information) Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Aprepitant (patient information) Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Aprepitant (patient information) Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Aprepitant (patient information) Clinical Studies in the drug label.

How Supplied

There is limited information regarding Aprepitant (patient information) How Supplied in the drug label.

Storage

There is limited information regarding Aprepitant (patient information) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Aprepitant (patient information) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Aprepitant (patient information) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Aprepitant (patient information) Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Aprepitant (patient information) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Aprepitant (patient information) Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Aprepitant (patient information) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

Why this medication is prescribed

Aprepitant is used with other medications to prevent upset stomach and vomiting caused by cancer chemotherapy treatment. Aprepitant is in a class of medications called antiemetics. It works by blocking the action of neurokinin, a natural substance in the brain that causes upset stomach and vomiting.

How this medication should be used

Aprepitant comes as a capsule to swallow with a drink. Aprepitant is usually taken once daily, with or without food, during the first few days of your cancer chemotherapy treatment. You will probably take aprepitant 1 hour before your first dose of chemotherapy, and then each morning for the next 2 days. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take aprepitant exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Aprepitant capsules come in two different strengths. Your doctor may prescribe both of the strengths for you to take at different times. You should be careful to take the right strength at the right time as directed by your doctor.

Aprepitant only works to prevent upset stomach and vomiting. If you already have these symptoms, do not take aprepitant. Call your doctor instead.

Aprepitant is used only during the first 3 days of cancer chemotherapy treatment cycles. Do not continue taking aprepitant longer than instructed by your doctor.

Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Special precautions

Before taking aprepitant:

• tell your doctor and pharmacist if you are allergic to aprepitant or any other medications.
• do not take aprepitant if you are taking astemizole (Hismanal), cisapride (Propulsid), pimozide (Orap), or terfenadine (Seldane).
• tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin); antifungals such as fluconzaole (Diflucan), itraconzaole (Sporanox), and ketoconazole (Nizoral); benzodiazepines such as alprazolam (Xanax), diazepam (Valium), and triazolam (Halcion); buspirone (BuSpar); calcium channel blockers such as amlodipine (Norvasc), diltiazem (Cardizem, Dilacor, Tiazac,), felodipine (Lexxel, Plendil), nifedipine (Adalat, Procardia), nisoldipine (Sular), and verapamil (Calan, Isoptin, Verelan); chlolesterol-lowering medications (statins) such as atorvastatin (Lipitor), fluvastatin (Lescol); lovastatin (Altocor, Mevacor), and simvastin (Zocor); cancer chemotherapy medications such as docetaxel (Taxotere), etoposide (Toposar, VePesid), ifosfamide (Ifex), imatinib (Gleevec), irinotecan (Camptosar), paclitaxel (Taxol), tamoxifen (Nolvadex), vinblastine, vincristine (Vincasar), and vinorelbine (Navelbine); carbamazepine (Tegretol); celecoxib (Celebrex); chlorpheniramine (Chlor-Trimeton, other cough, cold and sinus medications); cimetidine (Tagamet); clarithromycin (Biaxin); cyclosporine (Neoral, Sandimmune); danazol (Danocrine); delavirdine (Rescriptor); dexamethasone (Decadron); diclofenac (Arthrotec, Voltaren); efavirenz (Sustiva); erythromycin (E.E.S., E-Mycin, Erythrocin); ethosuximide (Zarontin); fluoxetine (Prozac, Sarafem); fluvoxamine (Luvox); glipizide (Glucotrol); haloperidol (Haldol); HIV protease inhibitors such as indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir), and saquinavir (Fortovase, Invirase); ibuprofen (Advil, Motrin); irbesartan (Avapro, Avalide); isoniazid (INH, Nydriazid); losartan (Cozaar, Hyzaar); methadone (Dolophine, Methadose); methylprednisolone (Medrol); metronidazole (Flagyl); naproxen ( Naprosyn); nefazadone (Serzone); oral contraceptives (birth control pills); phenobarbital (Luminal, Solfoton); phenytoin (Dilantin); piroxicam (Feldene); quinidine (Cardioglute, Quinaglute); quinine; rifabutin (Mycobutin); rifampin (Rifadin, Rimactane); tacrolimus (Prograf); sildenafil (Viagra); sulfamethoxazole (Bactrim, Septra, Sulfatrim); tolbutamide (Orinase); torsemide (Demadex); trazodone; troleandomycin (TAO); and zafirlukast (Accolate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
• tell your doctor what herbal products you are taking, especially St. John's Wort.
• tell your doctor if you have or have ever had liver disease.
• tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking aprepitant, call your doctor.

Special dietary instructions

Talk to your doctor about drinking grapefruit juice while taking this medicine.

What to do if you forget a dose

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Side Effects

Minor Side Effects

Aprepitant may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• weakness
• extreme tiredness
• dizziness
• diarrhea
• constipation
• stomach pain
• upset stomach
• hiccups
• loss of appetite

Severe Side Effects

Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

• hives
• skin rash
• difficulty breathing or swallowing
• swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
• hoarseness

Laboratory animals who were given aprepitant developed tumors. It is not known if aprepitant increases the risk of tumors in humans. Talk to your doctor about the risks of taking aprepitant.

Aprepitant may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].

Storage conditions needed for this medication

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Symptoms of overdose may include:

• drowsiness
• headache

Other information

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

Brand names

• Emend®